![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for deve... Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development. Show more
β Recipients include 20 individuals living with Duchenne muscular dystrophy and five siblings of individuals living with Duchenne Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on August 30, 2024 (the βGrant Dateβ) that were previously approved by...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the Morgan...
Bumble (NASDAQ:BMBL) – The dating and networking app reported a Q2 profit of $37.7 million (22 cents per share), beating the expected 15 cents, but its revenue was $268.6 million, below the...
Net product revenues for the second quarter 2024 totaled $360.5 million, a 51% increase over the same quarter of the prior year ELEVIDYS net product revenue for the quarter totaled $121.7...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -9.25 | -6.69465151625 | 138.17 | 138.71 | 126.815 | 703955 | 135.03745489 | CS |
4 | -4.46 | -3.34382965962 | 133.38 | 144.22 | 123.5 | 952085 | 134.20424739 | CS |
12 | 4.83 | 3.89233620759 | 124.09 | 173.1 | 115.74 | 1513231 | 146.57214182 | CS |
26 | 5.42 | 4.38866396761 | 123.5 | 173.1 | 109.91 | 1375919 | 136.18079015 | CS |
52 | 8.15 | 6.7483646601 | 120.77 | 173.1 | 55.25 | 1379753 | 118.27178173 | CS |
156 | 48.17 | 59.653250774 | 80.75 | 173.1 | 55.25 | 1185668 | 110.875441 | CS |
260 | 39.94 | 44.8864913464 | 88.98 | 181.83 | 55.25 | 1171454 | 108.70150107 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions